- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05094427
Perioperative Local Anesthesia Block in Spine Surgery
September 12, 2022 updated by: Columbia University
Perioperative Local Anesthesia Block in Spine Surgery: A Retrospective Chart Review
The purpose of the this study to evaluate the feasibility, safety, and efficacy of a fluoroscopically-guided dorsal ramus block placed by the operative neurosurgeon prior to lumbosacral surgery.
The study will consist of a retrospective analysis of a cohort of patients who underwent lumbosacral surgery patients between June 2018 and March 2021 with or without a preoperative fluoroscopically-guided dorsal ramus (DR) block placed by the operative neurosurgeon.
Study Overview
Status
Completed
Detailed Description
Spine surgery poses unique challenges in postoperative pain management.
Local anesthetic blocks, namely the erector spinae plane and thoracolumbar interfacial plane blocks, placed by anesthesia under ultrasound guidance have been shown to reduce postoperative pain after spinal surgery and decrease perioperative opioid requirements by as much as 50%.
Nonetheless these procedures are not routinely performed, likely due to logistical hurdles and lack of widespread knowledge of the procedure by anesthesiologists.
A preoperative dorsal ramus block performed by the operative neurosurgeon under fluoroscopy shows promise as an alternative approach to perioperative pain control.
The objective of this retrospective observational study is to evaluate the feasibility, safety, and efficacy of a dorsal ramus block block performed by a neurosurgeon under x-ray guidance prior to lumbar surgery.
The study will include a cohort of patients who have undergone lumbar spine surgery with or without the x-ray guided dorsal ramus block.
A retrospective chart review of these patients will be performed to assess for postoperative pain control, postoperative opioid requirements, time to block completion, length of stay, and adverse events.
Descriptive and comparative statistics will be performed.
No new data will be gathered from the subjects beyond pre-existing data within the medical record, and no new procedures will be performed as part of the study.
If the current study suggests that a dorsal ramus block performed by the operative neurosurgeon is feasible, safe, and effective, it will serve as a foundation for a randomized clinical trial of such a block among patients undergoing lumbar surgery.
Study Type
Observational
Enrollment (Actual)
232
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Irving Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The population consists of a convenience sample of patients undergoing lumbar spine surgery at a tertiary care academic medical center and an associated specialized spine hospital.
Description
Inclusion Criteria:
- Patients aged 18 years and older
- Patients undergoing lumbar spine surgery at any spinal level from L1 to sacrum (including decompression, discectomy, posterior fusion, interbody fusion, wound revision or washout, intradural tumor resection, treatment of vascular spinal lesion, tethered cord release, repair of cerebrospinal fluid (CSF) leak, hardware removal)
Exclusion Criteria:
- Patients undergoing surgery that includes thoracic levels
- Patients from whom pain scores could not be elicited in the immediate postoperative period due to mental status (e.g. prolonged intubation requirement, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Lumbar spine surgery with preoperative fluoroscopically-guided DR block
Patients who have undergone lumbar spine surgery with a fluoroscopically-guided DR block placed by the operative neurosurgeon prior to surgery.
These patients subsequently received standard of care general anesthesia and standard multimodality postoperative pain control.
|
Patients received bupivicaine injections delivered via 22-gauge spinal needle to the junction of the facet and transverse process or ala at multiple spinal levels (2.5-5 cc per injection of 0.25% or 0.5% bupivacaine).
Other Names:
|
Lumbar spine surgery without preoperative fluoroscopically-guided DR block
Patients who have undergone lumbar spine surgery without placement of a fluoroscopically-guided DR block.
These patients received standard of care general anesthesia and standard multimodality postoperative pain control.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
First visual analog scale (VAS) pain score in the post-anesthesia care unit (PACU)
Time Frame: Within the first 24 hours of surgery
|
The first VAS pain score recorded within the PACU on a 0-10 scale, with 0 indicating no pain (better outcome) and 10 indicating more pain (worse outcome).
|
Within the first 24 hours of surgery
|
Total PACU opioid requirements
Time Frame: Within the first 24 hours of surgery
|
Total opioids received within the PACU prior to discharge home or transfer to floor (oral morphine equivalents)
|
Within the first 24 hours of surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time required to perform block (in minutes)
Time Frame: Up to 30 minutes from start of DR block placement
|
Among patients who received DR block, total procedure time required to perform the block, intraoperatively.
|
Up to 30 minutes from start of DR block placement
|
Length of Stay (in hours to days)
Time Frame: Up to 30 days from completion of surgery during hospital course
|
Total time in hospital from end of surgery to discharge
|
Up to 30 days from completion of surgery during hospital course
|
Total number of adverse events
Time Frame: Up to 24 hours from start of DR block placement
|
Adverse cardiovascular events (hypotension, arrhythmia, cardiac arrest), adverse neurological events (unexpected neurological deficit, seizures, changes in intraoperative neuromonitoring)
|
Up to 24 hours from start of DR block placement
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christoper E. Mandigo, MD, Columbia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 10, 2021
Primary Completion (Actual)
March 31, 2022
Study Completion (Actual)
March 31, 2022
Study Registration Dates
First Submitted
October 14, 2021
First Submitted That Met QC Criteria
October 14, 2021
First Posted (Actual)
October 26, 2021
Study Record Updates
Last Update Posted (Actual)
September 13, 2022
Last Update Submitted That Met QC Criteria
September 12, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAT6085
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Disc Herniation
-
Shanghai General Hospital, Shanghai Jiao Tong University...RecruitingLumbar Disc Herniation | Lumbar Disc DegenerationChina
-
Shin Kong Wu Ho-Su Memorial HospitalTerminatedLumbar Disc Herniation | Lumbar Traction | Spinal Manipulation | Lumbar SurgeryTaiwan
-
Intrinsic TherapeuticsActive, not recruitingLumbar Disc Herniation | Annular Disc Tear | Annular Tear of Lumbar DiscBelgium, Germany
-
Allina Health SystemTwin Cities Spine CenterRecruitingLumbar Disc Herniation | Lumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Disc DiseaseUnited States
-
Holger JoswigCompletedLumbar Disc Herniation | Cervical Disc HerniationSwitzerland
-
Jaseng Medical FoundationRecruitingLumbar Disc HerniationKorea, Republic of
-
Firat UniversityRecruiting
-
Eastern Mediterranean UniversityRecruiting
-
Ramathibodi HospitalNot yet recruitingLumbar Disc Herniation
-
Zhou XingchenActive, not recruitingLumbar Disc HerniationChina
Clinical Trials on Preoperative fluoroscopically-guided dorsal ramus block placed by the operative neurosurgeon
-
Santiago Garcia-HernandezCompletedLow Back Pain | Chronic Pain | Analgesia, Epidural | Pain Measurement | Clinic, PainSpain